Is GLP-1 or tirzepatide better for weight loss?

GLP‑1 peptides are researched for appetite regulation and metabolic signaling. Tirzepatide is different because it’s studied as a dual agonist (GIP + GLP‑1), which may change energy‑balance signaling in some research models.

Whether one performs “better” depends on the endpoint (scale weight, fat mass, metabolic markers) and the study protocol. Pure Tested Peptides discusses dual‑agonist rationale in its GIP receptor article.

Disclaimer: The statements are for informational purposes only and not intended to treat, diagnose, or cure any disease and all products mentioned are for research purposes only and not for human use.